| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,389 |
| 52
Week Range: |
$0.2262 - $0.3069 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
24,594 |
55,087 |
115,588 |
| Total Buy Value |
$0 |
$39,199 |
$96,365 |
$132,870 |
| Total People Bought |
0 |
1 |
3 |
6 |
| Total Buy Transactions |
0 |
8 |
12 |
19 |
| Total Shares Sold |
0 |
2,068 |
2,068 |
3,568 |
| Total Sell Value |
$0 |
$4,053 |
$4,053 |
$4,525 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
1 |
1 |
2 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hedrick Marc H |
Chief Executive Officer |
• • – |
2023-11-20 |
4 |
S |
$1.96 |
$4,053 |
D/D |
(2,068) |
170 |
|
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-16 |
4 |
B |
$1.95 |
$1,950 |
D/D |
1,000 |
25,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-15 |
4 |
B |
$1.77 |
$1,770 |
D/D |
1,000 |
24,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-13 |
4 |
B |
$1.43 |
$5,720 |
D/D |
4,000 |
23,160 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-10 |
4 |
B |
$1.45 |
$2,900 |
D/D |
2,000 |
19,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-09 |
4 |
B |
$1.59 |
$6,676 |
D/D |
4,199 |
17,160 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-08 |
4 |
B |
$1.65 |
$8,250 |
D/D |
5,000 |
12,961 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-07 |
4 |
B |
$1.64 |
$9,840 |
D/D |
6,000 |
7,961 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-06 |
4 |
B |
$1.50 |
$2,093 |
D/D |
1,395 |
1,961 |
2.31 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-09-13 |
4 |
B |
$1.43 |
$10,022 |
D/D |
6,993 |
11,693 |
2.39 |
- |
|
| Petersen Greg |
Director |
– • – |
2023-09-11 |
4 |
B |
$1.70 |
$34,062 |
D/D |
20,000 |
24,166 |
2.39 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-06-06 |
4 |
B |
$3.98 |
$3,980 |
D/D |
1,000 |
4,700 |
2.31 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-05-03 |
4 |
B |
$3.64 |
$9,102 |
D/D |
2,500 |
3,700 |
2.39 |
- |
|
| Hawkins Richard J |
Director |
– • – |
2023-03-03 |
4 |
B |
$1,000.00 |
$1,000 |
D/D |
1 |
1 |
2.31 |
-25% |
|
| Lenk Robert P |
Director |
– • – |
2022-12-30 |
4 |
S |
$0.31 |
$472 |
D/D |
(1,500) |
8,500 |
|
18% |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2022-06-15 |
4 |
B |
$0.65 |
$3,240 |
D/D |
5,000 |
33,580 |
2.73 |
-19% |
|
| Clowes Howard |
Director |
– • – |
2022-06-02 |
4 |
B |
$0.57 |
$8,589 |
D/D |
15,000 |
18,000 |
2.39 |
-11% |
|
| Petersen Greg |
Director |
– • – |
2022-05-17 |
4 |
B |
$0.55 |
$16,500 |
D/D |
30,000 |
62,500 |
2.39 |
-11% |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2022-04-26 |
4 |
B |
$0.68 |
$1,710 |
D/D |
2,500 |
28,580 |
2.73 |
11% |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2022-04-26 |
4 |
B |
$0.69 |
$3,450 |
D/D |
5,000 |
26,080 |
2.73 |
11% |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2022-04-26 |
4 |
B |
$0.67 |
$2,016 |
D/D |
3,000 |
12,230 |
2.66 |
11% |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
B |
$1.10 |
$2,200 |
D/D |
2,000 |
9,230 |
2.66 |
-51% |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2021-11-02 |
4 |
B |
$1.86 |
$1,864 |
D/D |
1,000 |
7,230 |
2.66 |
-48% |
|
| Petersen Greg |
Director |
– • – |
2021-10-27 |
4 |
B |
$1.72 |
$21,500 |
D/D |
12,500 |
32,500 |
2.39 |
-40% |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2021-10-26 |
4 |
B |
$1.67 |
$3,339 |
D/D |
2,000 |
6,230 |
2.66 |
-39% |
|
102 Records found
|
|
Page 1 of 5 |
|
|
